Solvency ratios also known as long-term debt ratios measure a company ability to meet long-term obligations.
Solvency Ratios (Summary)
Debt Ratios
Coverage Ratios
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
The solvency profile demonstrates a conservative approach to capital structure, characterized by exceptionally low debt levels relative to equity, capital, and total assets across the analyzed period.
- Debt Utilization Ratios
- Ratios incorporating operating lease liabilities remained consistently low and stable from 2019 to 2022. Debt to equity and debt to capital ratios fluctuated minimally between 0.03 and 0.04, while the debt to assets ratio remained stagnant at 0.02. These figures indicate a minimal reliance on borrowed funds to finance operations and asset acquisition.
- Financial Leverage
- Financial leverage exhibited moderate fluctuations, beginning at 1.64 in 2018 and peaking at 1.86 in 2019. A contraction to 1.49 was observed in 2020, followed by a recovery and subsequent stabilization at approximately 1.64 to 1.65 during the 2021 and 2022 fiscal years.
- Fixed Charge Coverage
- The fixed charge coverage ratio showed significant volatility over the five-year span. A downward trend was observed from 28.76 in 2018 to a low of 14.62 in 2020. This was followed by a sharp increase to a peak of 31.46 in 2021, before declining again to 16.80 in 2022. Despite these variations, the ratios remained substantially above 1.0, indicating a sustained and comfortable capacity to meet fixed financial obligations.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Debt to Equity
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | ||||||
| Total debt | —) | —) | —) | —) | —) | |
| Stockholders’ equity | 3,601,358) | 3,622,714) | 3,233,865) | 1,346,169) | 1,252,891) | |
| Solvency Ratio | ||||||
| Debt to equity1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Benchmarks | ||||||
| Debt to Equity, Competitors2 | ||||||
| Abbott Laboratories | 0.46 | 0.50 | — | — | — | |
| Elevance Health Inc. | 0.66 | 0.64 | — | — | — | |
| Intuitive Surgical Inc. | 0.00 | 0.00 | — | — | — | |
| Medtronic PLC | 0.46 | 0.51 | — | — | — | |
| UnitedHealth Group Inc. | 0.74 | 0.64 | — | — | — | |
| Debt to Equity, Sector | ||||||
| Health Care Equipment & Services | 0.57 | 0.55 | — | — | — | |
| Debt to Equity, Industry | ||||||
| Health Care | 0.72 | 0.80 | — | — | — | |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Debt to equity = Total debt ÷ Stockholders’ equity
= 0 ÷ 3,601,358 = 0.00
2 Click competitor name to see calculations.
The available financial information allows for an evaluation of the equity component of the company's solvency position, although a complete debt-to-equity analysis is precluded by the absence of reported debt figures.
- Stockholders' Equity Trend
- A significant upward trajectory in stockholders' equity is observed from 2018 through 2021. Equity increased from US$ 1,252,891 thousand in 2018 to US$ 3,622,714 thousand by 2021, representing a substantial expansion of the net asset base. The most pronounced growth occurred between 2019 and 2020, during which equity more than doubled. A marginal contraction is noted in 2022, with the value adjusting to US$ 3,601,358 thousand.
- Solvency Ratio Interpretation
- Because total debt values are not provided for the 2018 to 2022 period, the debt to equity ratio cannot be computed. While the substantial increase in stockholders' equity generally improves a company's solvency position by providing a larger cushion for creditors, the specific leverage ratio remains indeterminate without corresponding debt data.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Debt to Equity (including Operating Lease Liability)
Align Technology Inc., debt to equity (including operating lease liability) calculation, comparison to benchmarks
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | ||||||
| Total debt | —) | —) | —) | —) | —) | |
| Current operating lease liabilities | 26,574) | 22,719) | 21,735) | 15,737) | —) | |
| Long-term operating lease liabilities | 100,334) | 102,656) | 64,445) | 43,463) | —) | |
| Total debt (including operating lease liability) | 126,908) | 125,375) | 86,180) | 59,200) | —) | |
| Stockholders’ equity | 3,601,358) | 3,622,714) | 3,233,865) | 1,346,169) | 1,252,891) | |
| Solvency Ratio | ||||||
| Debt to equity (including operating lease liability)1 | 0.04 | 0.03 | 0.03 | 0.04 | 0.00 | |
| Benchmarks | ||||||
| Debt to Equity (including Operating Lease Liability), Competitors2 | ||||||
| Abbott Laboratories | 0.49 | 0.54 | — | — | — | |
| Elevance Health Inc. | 0.69 | 0.67 | — | — | — | |
| Intuitive Surgical Inc. | 0.01 | 0.01 | — | — | — | |
| Medtronic PLC | 0.48 | 0.53 | — | — | — | |
| UnitedHealth Group Inc. | 0.80 | 0.70 | — | — | — | |
| Debt to Equity (including Operating Lease Liability), Sector | ||||||
| Health Care Equipment & Services | 0.61 | 0.58 | — | — | — | |
| Debt to Equity (including Operating Lease Liability), Industry | ||||||
| Health Care | 0.76 | 0.83 | — | — | — | |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Debt to equity (including operating lease liability) = Total debt (including operating lease liability) ÷ Stockholders’ equity
= 126,908 ÷ 3,601,358 = 0.04
2 Click competitor name to see calculations.
The solvency profile exhibits a highly conservative capital structure characterized by minimal reliance on borrowed funds relative to shareholder equity. While nominal debt levels increased over the analyzed period, the simultaneous and more aggressive expansion of equity maintained a very low leverage position.
- Total Debt Trends
- Total debt, including operating lease liabilities, showed a consistent upward trajectory, increasing from US$ 59.2 million in 2019 to US$ 126.9 million by the end of 2022. The most significant absolute increase occurred between 2020 and 2021, where liabilities grew by approximately US$ 39.2 million.
- Stockholders' Equity Growth
- Equity experienced substantial growth, rising from US$ 1.25 billion in 2018 to US$ 3.60 billion in 2022. A critical surge is observed between 2019 and 2020, during which equity increased by approximately US$ 1.89 billion, significantly enhancing the organization's net asset base.
- Debt to Equity Ratio Stability
- The debt to equity ratio remained remarkably stable and low, fluctuating only between 0.03 and 0.04 from 2019 through 2022. This stability indicates that the increase in total debt was effectively absorbed by the growth in equity, ensuring that the leverage ratio did not escalate despite the rise in nominal liabilities.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Debt to Capital
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | ||||||
| Total debt | —) | —) | —) | —) | —) | |
| Stockholders’ equity | 3,601,358) | 3,622,714) | 3,233,865) | 1,346,169) | 1,252,891) | |
| Total capital | 3,601,358) | 3,622,714) | 3,233,865) | 1,346,169) | 1,252,891) | |
| Solvency Ratio | ||||||
| Debt to capital1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Benchmarks | ||||||
| Debt to Capital, Competitors2 | ||||||
| Abbott Laboratories | 0.31 | 0.34 | — | — | — | |
| Elevance Health Inc. | 0.40 | 0.39 | — | — | — | |
| Intuitive Surgical Inc. | 0.00 | 0.00 | — | — | — | |
| Medtronic PLC | 0.31 | 0.34 | — | — | — | |
| UnitedHealth Group Inc. | 0.43 | 0.39 | — | — | — | |
| Debt to Capital, Sector | ||||||
| Health Care Equipment & Services | 0.36 | 0.35 | — | — | — | |
| Debt to Capital, Industry | ||||||
| Health Care | 0.42 | 0.44 | — | — | — | |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Debt to capital = Total debt ÷ Total capital
= 0 ÷ 3,601,358 = 0.00
2 Click competitor name to see calculations.
The capitalization structure exhibits a period of aggressive expansion followed by a plateau. Total capital demonstrated a significant upward trajectory from 2018 to 2021, reflecting a substantial increase in the company's resource base.
- Total Capital Evolution
- A substantial increase is noted between December 31, 2019, and December 31, 2020, where total capital grew from 1,346,169 thousand US$ to 3,233,865 thousand US$. This growth trend persisted into 2021, peaking at 3,622,714 thousand US$, before a marginal contraction to 3,601,358 thousand US$ occurred in 2022.
- Solvency Ratio Determination
- The calculation and subsequent analysis of the debt to capital ratio are not possible due to the unavailability of total debt figures. Without these values, the company's reliance on debt relative to its total capital cannot be evaluated, leaving the solvency trend for this specific metric undetermined.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Debt to Capital (including Operating Lease Liability)
Align Technology Inc., debt to capital (including operating lease liability) calculation, comparison to benchmarks
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | ||||||
| Total debt | —) | —) | —) | —) | —) | |
| Current operating lease liabilities | 26,574) | 22,719) | 21,735) | 15,737) | —) | |
| Long-term operating lease liabilities | 100,334) | 102,656) | 64,445) | 43,463) | —) | |
| Total debt (including operating lease liability) | 126,908) | 125,375) | 86,180) | 59,200) | —) | |
| Stockholders’ equity | 3,601,358) | 3,622,714) | 3,233,865) | 1,346,169) | 1,252,891) | |
| Total capital (including operating lease liability) | 3,728,266) | 3,748,089) | 3,320,045) | 1,405,369) | 1,252,891) | |
| Solvency Ratio | ||||||
| Debt to capital (including operating lease liability)1 | 0.03 | 0.03 | 0.03 | 0.04 | 0.00 | |
| Benchmarks | ||||||
| Debt to Capital (including Operating Lease Liability), Competitors2 | ||||||
| Abbott Laboratories | 0.33 | 0.35 | — | — | — | |
| Elevance Health Inc. | 0.41 | 0.40 | — | — | — | |
| Intuitive Surgical Inc. | 0.01 | 0.01 | — | — | — | |
| Medtronic PLC | 0.32 | 0.35 | — | — | — | |
| UnitedHealth Group Inc. | 0.45 | 0.41 | — | — | — | |
| Debt to Capital (including Operating Lease Liability), Sector | ||||||
| Health Care Equipment & Services | 0.38 | 0.37 | — | — | — | |
| Debt to Capital (including Operating Lease Liability), Industry | ||||||
| Health Care | 0.43 | 0.45 | — | — | — | |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Debt to capital (including operating lease liability) = Total debt (including operating lease liability) ÷ Total capital (including operating lease liability)
= 126,908 ÷ 3,728,266 = 0.03
2 Click competitor name to see calculations.
The solvency analysis indicates a highly conservative capital structure characterized by minimal reliance on debt financing relative to the overall capital base. Throughout the observed period, the company maintained a strong solvency position, with capital growth significantly outpacing the accumulation of liabilities.
- Total Debt Trends
- Total debt, inclusive of operating lease liabilities, demonstrated a consistent upward trend from 2019 to 2022. The amount increased from 59,200 thousand US dollars in 2019 to 126,908 thousand US dollars by the end of 2022, representing a substantial increase in absolute debt obligations over the four-year span.
- Total Capital Expansion
- Total capital experienced rapid growth, most notably between 2019 and 2020, when it increased from 1,405,369 thousand US dollars to 3,320,045 thousand US dollars. This growth trend continued into 2021, peaking at 3,748,089 thousand US dollars, before seeing a marginal decline to 3,728,266 thousand US dollars in 2022.
- Debt to Capital Ratio Stability
- The debt to capital ratio remained remarkably stable and low. After a minor decrease from 0.04 in 2019 to 0.03 in 2020, the ratio held constant at 0.03 through 2021 and 2022. This stability suggests that the increase in total debt was negligible compared to the scale of total capital, ensuring that the company's financial leverage remained at a very low level.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Debt to Assets
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | ||||||
| Total debt | —) | —) | —) | —) | —) | |
| Total assets | 5,947,947) | 5,942,110) | 4,829,683) | 2,500,702) | 2,052,458) | |
| Solvency Ratio | ||||||
| Debt to assets1 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Benchmarks | ||||||
| Debt to Assets, Competitors2 | ||||||
| Abbott Laboratories | 0.23 | 0.24 | — | — | — | |
| Elevance Health Inc. | 0.23 | 0.24 | — | — | — | |
| Intuitive Surgical Inc. | 0.00 | 0.00 | — | — | — | |
| Medtronic PLC | 0.27 | 0.28 | — | — | — | |
| UnitedHealth Group Inc. | 0.23 | 0.22 | — | — | — | |
| Debt to Assets, Sector | ||||||
| Health Care Equipment & Services | 0.23 | 0.23 | — | — | — | |
| Debt to Assets, Industry | ||||||
| Health Care | 0.28 | 0.30 | — | — | — | |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Debt to assets = Total debt ÷ Total assets
= 0 ÷ 5,947,947 = 0.00
2 Click competitor name to see calculations.
Analysis of the solvency components indicates a significant expansion of the asset base over the five-year period ending December 31, 2022.
- Total Assets Growth
- A consistent upward trajectory in total assets is observed from 2018 through 2021. The asset base grew from approximately 2.05 billion US dollars in 2018 to 5.95 billion US dollars by 2022. A particularly sharp increase occurred between December 31, 2019, and December 31, 2020, during which total assets increased by approximately 93%.
- Asset Stabilization
- Growth slowed considerably in the final year of the period. Between December 31, 2021, and December 31, 2022, total assets remained relatively stagnant, moving from 5.942 billion to 5.948 billion US dollars, indicating a stabilization of the company's asset position.
- Debt to Assets Ratio Interpretation
- The determination of the debt to assets ratio is not possible due to the absence of total debt figures for the specified period. Consequently, the proportion of assets financed by debt and the resulting impact on overall solvency cannot be quantified.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Debt to Assets (including Operating Lease Liability)
Align Technology Inc., debt to assets (including operating lease liability) calculation, comparison to benchmarks
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | ||||||
| Total debt | —) | —) | —) | —) | —) | |
| Current operating lease liabilities | 26,574) | 22,719) | 21,735) | 15,737) | —) | |
| Long-term operating lease liabilities | 100,334) | 102,656) | 64,445) | 43,463) | —) | |
| Total debt (including operating lease liability) | 126,908) | 125,375) | 86,180) | 59,200) | —) | |
| Total assets | 5,947,947) | 5,942,110) | 4,829,683) | 2,500,702) | 2,052,458) | |
| Solvency Ratio | ||||||
| Debt to assets (including operating lease liability)1 | 0.02 | 0.02 | 0.02 | 0.02 | 0.00 | |
| Benchmarks | ||||||
| Debt to Assets (including Operating Lease Liability), Competitors2 | ||||||
| Abbott Laboratories | 0.24 | 0.26 | — | — | — | |
| Elevance Health Inc. | 0.24 | 0.25 | — | — | — | |
| Intuitive Surgical Inc. | 0.01 | 0.01 | — | — | — | |
| Medtronic PLC | 0.27 | 0.29 | — | — | — | |
| UnitedHealth Group Inc. | 0.25 | 0.24 | — | — | — | |
| Debt to Assets (including Operating Lease Liability), Sector | ||||||
| Health Care Equipment & Services | 0.25 | 0.25 | — | — | — | |
| Debt to Assets (including Operating Lease Liability), Industry | ||||||
| Health Care | 0.29 | 0.31 | — | — | — | |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Debt to assets (including operating lease liability) = Total debt (including operating lease liability) ÷ Total assets
= 126,908 ÷ 5,947,947 = 0.02
2 Click competitor name to see calculations.
The analysis of solvency metrics indicates a highly conservative capital structure characterized by minimal leverage relative to the asset base. While both total debt and total assets experienced growth between 2019 and 2022, the expansion of the asset base occurred at a rate that neutralized the impact of increased borrowing, maintaining a consistent risk profile.
- Total Assets Trend
- A substantial upward trend is evident in the total assets, which grew from US$ 2,052,458 thousand in 2018 to US$ 5,947,947 thousand by the end of 2022. The most significant acceleration occurred between 2019 and 2020, during which the asset base nearly doubled.
- Debt Accumulation
- Total debt, inclusive of operating lease liabilities, exhibited a steady increase from US$ 59,200 thousand in 2019 to US$ 126,908 thousand in 2022. This represents a more than twofold increase in absolute debt levels over the observed period.
- Debt to Assets Ratio Interpretation
- The debt to assets ratio remained stagnant at 0.02 from 2019 through 2022. This indicates that despite the growth in nominal debt, the proportion of assets financed through debt remained negligible. The stability of this ratio suggests an extremely low reliance on external leverage and a strong capacity to cover long-term obligations.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Financial Leverage
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | ||||||
| Total assets | 5,947,947) | 5,942,110) | 4,829,683) | 2,500,702) | 2,052,458) | |
| Stockholders’ equity | 3,601,358) | 3,622,714) | 3,233,865) | 1,346,169) | 1,252,891) | |
| Solvency Ratio | ||||||
| Financial leverage1 | 1.65 | 1.64 | 1.49 | 1.86 | 1.64 | |
| Benchmarks | ||||||
| Financial Leverage, Competitors2 | ||||||
| Abbott Laboratories | 2.03 | 2.10 | — | — | — | |
| Elevance Health Inc. | 2.83 | 2.70 | — | — | — | |
| Intuitive Surgical Inc. | 1.17 | 1.14 | — | — | — | |
| Medtronic PLC | 1.73 | 1.81 | — | — | — | |
| UnitedHealth Group Inc. | 3.16 | 2.96 | — | — | — | |
| Financial Leverage, Sector | ||||||
| Health Care Equipment & Services | 2.46 | 2.37 | — | — | — | |
| Financial Leverage, Industry | ||||||
| Health Care | 2.57 | 2.69 | — | — | — | |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Financial leverage = Total assets ÷ Stockholders’ equity
= 5,947,947 ÷ 3,601,358 = 1.65
2 Click competitor name to see calculations.
Between 2018 and 2022, a significant expansion of the balance sheet is evident, characterized by a substantial increase in both total assets and stockholders' equity. Total assets grew from US$ 2.05 billion in 2018 to US$ 5.95 billion by the end of 2022, representing a near-tripling of the asset base. This growth was most pronounced between 2019 and 2021, after which asset levels stabilized.
- Financial Leverage Volatility
- The financial leverage ratio exhibited notable fluctuations during the analyzed period. After rising from 1.64 in 2018 to a peak of 1.86 in 2019, the ratio experienced a sharp decline to 1.49 in 2020. This decrease coincided with a dramatic increase in stockholders' equity, which rose from US$ 1.35 billion in 2019 to US$ 3.23 billion in 2020, indicating a significant shift toward equity financing and a reduction in relative financial risk during that year.
- Capital Structure Stabilization
- Following the volatility observed through 2020, the financial leverage ratio returned to and stabilized at previous levels. From 2021 to 2022, the ratio remained nearly constant at 1.64 and 1.65, respectively. This consistency reflects a period of stagnation in both total assets and stockholders' equity, suggesting a steady state in the company's capital structure and leverage strategy during the final two years of the period.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Interest Coverage
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | ||||||
| Net income | 361,573) | 772,020) | 1,775,888) | 442,776) | 400,235) | |
| Add: Income tax expense | 237,484) | 240,403) | (1,396,939) | 112,347) | 57,723) | |
| Add: Interest expense | —) | —) | —) | —) | —) | |
| Earnings before interest and tax (EBIT) | 599,057) | 1,012,423) | 378,949) | 555,123) | 457,958) | |
| Solvency Ratio | ||||||
| Interest coverage1 | — | — | — | — | — | |
| Benchmarks | ||||||
| Interest Coverage, Competitors2 | ||||||
| Abbott Laboratories | 15.89 | 16.41 | — | — | — | |
| Elevance Health Inc. | 10.13 | 10.93 | — | — | — | |
| Intuitive Surgical Inc. | — | — | — | — | — | |
| Medtronic PLC | 10.98 | 5.21 | — | — | — | |
| UnitedHealth Group Inc. | 13.59 | 14.44 | — | — | — | |
| Interest Coverage, Sector | ||||||
| Health Care Equipment & Services | 13.22 | 12.30 | — | — | — | |
| Interest Coverage, Industry | ||||||
| Health Care | 14.75 | 14.14 | — | — | — | |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Interest coverage = EBIT ÷ Interest expense
= 599,057 ÷ 0 = —
2 Click competitor name to see calculations.
The available financial data demonstrates significant volatility in Earnings Before Interest and Tax (EBIT) between 2018 and 2022, which serves as the primary numerator for determining interest coverage and overall solvency.
- EBIT Performance Trends
- A growth phase occurred between 2018 and 2019, with EBIT increasing from 457,958 to 555,123 thousand US$. This was followed by a contraction in 2020, where earnings fell to 378,949 thousand US$. A substantial recovery and peak were observed in 2021, with EBIT reaching 1,012,423 thousand US$, before moderating to 599,057 thousand US$ in 2022.
- Interest Coverage Capacity
- Due to the absence of recorded interest expense figures, a precise interest coverage ratio cannot be computed for the period. However, the operational capacity to service debt fluctuates in alignment with EBIT. The surge in 2021 suggests a period of maximum potential solvency strength, whereas the 2020 decline indicates a temporary reduction in the margin of safety for meeting interest obligations.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?
Fixed Charge Coverage
| Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in thousands) | ||||||
| Net income | 361,573) | 772,020) | 1,775,888) | 442,776) | 400,235) | |
| Add: Income tax expense | 237,484) | 240,403) | (1,396,939) | 112,347) | 57,723) | |
| Add: Interest expense | —) | —) | —) | —) | —) | |
| Earnings before interest and tax (EBIT) | 599,057) | 1,012,423) | 378,949) | 555,123) | 457,958) | |
| Add: Operating lease cost | 37,919) | 33,241) | 27,825) | 22,778) | 16,500) | |
| Earnings before fixed charges and tax | 636,976) | 1,045,664) | 406,774) | 577,901) | 474,458) | |
| Interest expense | —) | —) | —) | —) | —) | |
| Operating lease cost | 37,919) | 33,241) | 27,825) | 22,778) | 16,500) | |
| Fixed charges | 37,919) | 33,241) | 27,825) | 22,778) | 16,500) | |
| Solvency Ratio | ||||||
| Fixed charge coverage1 | 16.80 | 31.46 | 14.62 | 25.37 | 28.76 | |
| Benchmarks | ||||||
| Fixed Charge Coverage, Competitors2 | ||||||
| Abbott Laboratories | 10.10 | 10.21 | — | — | — | |
| Elevance Health Inc. | 8.82 | 8.48 | — | — | — | |
| Intuitive Surgical Inc. | 63.52 | 93.66 | — | — | — | |
| Medtronic PLC | 7.79 | 4.31 | — | — | — | |
| UnitedHealth Group Inc. | 8.77 | 8.80 | — | — | — | |
| Fixed Charge Coverage, Sector | ||||||
| Health Care Equipment & Services | 9.07 | 8.36 | — | — | — | |
| Fixed Charge Coverage, Industry | ||||||
| Health Care | 10.95 | 10.48 | — | — | — | |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31).
1 2022 Calculation
Fixed charge coverage = Earnings before fixed charges and tax ÷ Fixed charges
= 636,976 ÷ 37,919 = 16.80
2 Click competitor name to see calculations.
The analysis of solvency through the fixed charge coverage ratio reveals a period of significant volatility in earnings capacity relative to a steady increase in fixed obligations from 2018 to 2022.
- Earnings before Fixed Charges and Tax
- Earnings exhibited substantial fluctuations, starting at US$ 474.4 million in 2018 and reaching a peak of US$ 1,045.6 million in 2021. A notable contraction occurred in 2020, where earnings fell to US$ 406.7 million, followed by a subsequent decline to US$ 636.9 million in 2022.
- Fixed Charge Obligations
- A consistent upward trajectory is observed in fixed charges, which grew annually from US$ 16.5 million in 2018 to US$ 37.9 million in 2022. This indicates a steady increase in the company's recurring financial commitments over the five-year period.
- Fixed Charge Coverage Ratio
- The coverage ratio demonstrates high solvency, although it is subject to the volatility of earnings. The ratio declined from 28.76 in 2018 to a period low of 14.62 in 2020. A sharp recovery occurred in 2021, with the ratio peaking at 31.46, before moderating to 16.80 by the end of 2022.
Overall, the divergence between fluctuating operating earnings and steadily increasing fixed costs has resulted in an inconsistent coverage trend. Despite these fluctuations, the ratio remained significantly above 1.0 throughout the entire period, indicating that fixed obligations were comfortably covered by earnings in each fiscal year.
AI Ask an analyst for more
Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.
How can I help you?